Saturday 17 October 2026
Export WORX’s income statement to Excel — free account
SCWorx Corp.
WORX Healthcare Health Information Services
SCWorx Corp.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 3.75% from fiscal 2024. In the quarter to June 2026, revenue grew 3.43%, EPS grew 98.4% and free cash flow grew 88.0%, each against the same quarter a year earlier.
1.40
0.61
−30.35%
Follow WORX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
2 | 4 | 4 | 5 |
| (74.23%) | (76.35%) | (65.51%) | (38.06%) | ||
| (56.80%) | (62.41%) | (55.47%) | (32.83%) | ||
ROIC |
(13.48%) | (10.88%) | (8.33%) | (6.48%) | |
Return on Tangible Assets |
(2,477.83%) | (344.50%) | (369.26%) | (252.90%) | |
Average Days of Receivables |
80.19 | 39.75 | 39.57 | 32.66 | |
Free Cash Flow per Share |
(32.82) | (38.42) | (16.71) | (10.12) | |
Free Cash Flow |
(1.55) | (1.55) | (1.48) | (0.90) | |
Capital Expenditures |
— | (0.01) | (0.09) | (0.16) | |
| Other line items | |||||
Cash ROIC |
(23.17%) | (17.65%) | (17.60%) | (11.02%) | |
Accounts Receivable Turnover |
4.81 | 8.39 | 11.85 | 8.68 | |
Accounts Payable Turnover |
1.62 | 1.99 | 2.10 | 2.16 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
137.82 | 108.74 | 119.08 | 130.22 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
45.09% | 47.51% | 49.99% | 48.35% | |
Share Based Compensation of Revenue |
3.95% | 4.84% | 5.23% | 2.64% | |
Interest Coverage |
(0.40) | (0.32) | (0.26) | (0.44) | |
Operating CF/Net income |
0.40 | 0.35 | 0.34 | 0.32 | |
Depreciation/Fixed assets |
0.00 | 255.06 | 275.05 | 140.39 | |
Capex/Depreciation |
0.00 | 0.00 | (0.03) | (0.13) | |
Revenue per Share |
58.99 | 71.23 | 32.83 | 32.76 | |
Operating CF per Share |
(32.82) | (38.21) | (15.74) | (8.35) | |
Capex per Share |
0.00 | (0.22) | (0.97) | (1.77) | |
Capex to Sales |
0.00 | 0.00 | 0.03 | 0.05 |
Columns are period end dates